We are live on ! Find out more
RCA

Resonant Capital Advisors Portfolio holdings

AUM $2.09B
1-Year Est. Return 20.07%
This Fund
S&P 500
This Quarter Est. Return
+14.07%
1 Year Est. Return
+20.07%
3 Year Est. Return
+50.65%
5 Year Est. Return
+54.9%
10 Year Est. Return
AUM
$422M
AUM Growth
+$71.5M
Cap. Flow
+$24.1M
Cap. Flow %
5.71%
Top 10 Hldgs %
47.33%
Holding
175
New
18
Increased
95
Reduced
39
Closed
4

Sector Composition

Rank Sector Weight
1 Technology 6.93%
2 Financials 5.5%
3 Healthcare 5.44%
4 Consumer Discretionary 3.05%
5 Consumer Staples 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HD icon
76
Home Depot
HD
$349B
$1.15M 0.27%
4,335
-877
-17% -$241K
EA icon
77
Electronic Arts
EA
$1.14M 0.27%
7,966
+1,258
+19% +$162K
VEU icon
78
Vanguard FTSE All-World ex-US ETF
VEU
$67.8B
$1.1M 0.26%
18,791
+6,966
+59% +$380K
IWF icon
79
iShares Russell 1000 Growth ETF
IWF
$127B
$1.06M 0.25%
17,644
-3,092
-15% -$176K
ABT icon
80
Abbott
ABT
$187B
$1.03M 0.24%
9,400
-300
-3% -$32.6K
JPST icon
81
JPMorgan Ultra-Short Income ETF
JPST
$40.3B
$1.02M 0.24%
20,147
+12,606
+167% +$640K
DIA icon
82
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46.3B
$1.01M 0.24%
3,300
VDE icon
83
Vanguard Energy ETF
VDE
$9.84B
$892K 0.21%
+17,207
New +$804K
PRFZ icon
84
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.84B
$857K 0.2%
28,400
EFA icon
85
iShares MSCI EAFE ETF
EFA
$79.4B
$854K 0.2%
11,709
-6
-0.1% -$410
ABBV icon
86
AbbVie
ABBV
$431B
$848K 0.2%
7,911
-312
-4% -$30K
XOM icon
87
ExxonMobil
XOM
$642B
$847K 0.2%
20,540
-5,952
-22% -$223K
EEM icon
88
iShares MSCI Emerging Markets ETF
EEM
$29.2B
$787K 0.19%
15,230
-1,254
-8% -$60.3K
BIIB icon
89
Biogen
BIIB
$30.5B
$774K 0.18%
3,160
+563
+22% +$145K
SUSA icon
90
iShares ESG Optimized MSCI USA ETF
SUSA
$4.15B
$749K 0.18%
+9,095
New +$711K
VEA icon
91
Vanguard FTSE Developed Markets ETF
VEA
$234B
$708K 0.17%
15,000
USB icon
92
US Bancorp
USB
$99.4B
$694K 0.16%
14,764
-250
-2% -$10.6K
JMST icon
93
JPMorgan Ultra-Short Municipal Income ETF
JMST
$7.1B
$685K 0.16%
+13,426
New +$685K
DVY icon
94
iShares Select Dividend ETF
DVY
$23.5B
$673K 0.16%
7,000
-1,050
-13% -$95.3K
XLU icon
95
State Street Utilities Select Sector SPDR ETF
XLU
$22.4B
$627K 0.15%
20,000
TMO icon
96
Thermo Fisher Scientific
TMO
$214B
$599K 0.14%
1,285
-215
-14% -$101K
BA icon
97
Boeing
BA
$184B
$587K 0.14%
2,743
-54
-2% -$10.4K
CPRT icon
98
Copart
CPRT
$26.9B
$586K 0.14%
18,436
+616
+3% +$17.9K
EW icon
99
Edwards Lifesciences
EW
$51.5B
$562K 0.13%
6,165
-300
-5% -$24.9K
NKE icon
100
Nike
NKE
$62.3B
$538K 0.13%
3,804

Similar funds

Resonant Capital Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Resonant Capital Advisors held 175 positions worth $422M, up 20% from $351M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Resonant Capital Advisors deployed $24.1M of net new capital in Q4 2020, opening 18 new positions and adding to 95 existing holdings. Its largest new stake was State Street SPDR S&P 600 Small Cap Value ETF: 40,941 shares worth $2.71M.

By sector, the portfolio is most concentrated in Technology at 6.9% of assets, down from 7.3% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Invesco BuyBack Achievers ETF, an estimated $933K trimmed.

  • Resonant Capital Advisors's largest Q4 2020 buy was State Street SPDR S&P 600 Small Cap Value ETF: 40,941 shares worth $2.71M.
  • Resonant Capital Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $2.44M increase.
  • Resonant Capital Advisors's biggest Q4 2020 reduction was Invesco BuyBack Achievers ETF, cutting an estimated $933K.
  • Resonant Capital Advisors fully exited iShares iBonds Dec 2020 Term Corporate ETF in Q4 2020, selling an estimated $352K.
  • Resonant Capital Advisors's ten largest holdings make up 47% of its $422M portfolio in Q4 2020.
  • Resonant Capital Advisors opened 18 new positions and closed 4 in Q4 2020.
  • Resonant Capital Advisors's portfolio value rose 20% quarter-over-quarter to $422M.

Based on Resonant Capital Advisors's 13F filing for Q4 2020, filed 15 Jan 2021.